Tokyo, June 22 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061995) titled 'A Multicenter Retrospective Study of Neoadjuvant Therapy for Biological Borderline Resectable Pancreatic Cancer' on June 22.
Study Type:
Observational
Primary Sponsor:
Institute - Osaka University
Condition:
Condition - Pancreatic invasive ductal adenocarcinoma
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the current practice of neoadjuvant therapy in patients with biological borderline resectable pancreatic cancer with elevated CA19-9 levels and to provide insights into the development of optimal neoadjuvant treatment strategies...